Eurofound's EU PolicyWatch collates information on the responses of government and social partners to the COVID-19 crisis, the war in Ukraine, rising inflation, as well as gathering examples of company practices aimed at mitigating the social and economic impacts.
Factsheet for measure LT-2020-12/1389 – measures in Lithuania
| Country | Lithuania , applies nationwide |
| Time period | Open ended, started on 16 March 2020 |
| Context | COVID-19 |
| Type | Company practices |
| Category |
Reorientation of business activities
– Change of production/Innovation |
| Author | Inga Blaziene, Rasa Mieziene, Lithuanian Centre for Social Sciences |
| Measure added | 03 November 2020 (updated 02 February 2021) |
Lithuanian company Lesta, which is the manufacture of operational fluids (windscreen cleaning liquids, cooling fluids, vehicle oils, etc.) and care preparations for vehicles, started producing disinfectant liquids for hands and surfaces after the outbreak of the COVID-19 pandemic. The company decided to start such production when the general public and especially the medical staff faced with a dramatic shortage of disinfectant liquids in the circumstances of the COVID-19 pandemic. Such a transformation during the quarantine period allowed the company to enter a new product group with almost no costs for advertising.
As soon as the COVID-19 pandemic erupted in the world and many countries started facing shortages of disinfection products, the company decided not to wait for the virus to spread in Lithuania and start producing disinfectant liquids. This option was considered because the company had all the technical capabilities to produce such liquids, i.e. production lines adapted to dispense large quantities of chemical liquids, own laboratory and chemists able to ensure the quality of the new product. Moreover, the main raw material, ethyl alcohol, has already been used in the company’s products for vehicles.
The company took the risk of ordering large quantities of basic raw materials, containers and caps even prior to being issued a permit from the Ministry of Health of the Republic of Lithuania (MH) to produce disinfectant liquids. Yet, the risk paid off, and the company was one of the first to start producing disinfectants as soon as permission was obtained from the MH. Moreover, the company managed to save money, because the price of neutral spirits soon grew significantly and there was a shortage of containers and caps on the market, but the company had them in place because it had purchased the materials in advance. In order to urgently meet the need for disinfectants in Lithuania, the plant worked two shifts on weekdays and weekends.
The liquid was first supplied to state institutions (hospitals, clinics) and then to retail chains, pharmacies and gas stations.
As the product was highly demanded, the company entered a new product group with almost no advertising costs. In addition, the launch of the new product during the pandemic increased the awareness of the Lesta brand, which became known not only in the category of automotive liquids, but also in the category of cosmetics and hygiene products.
| Workers | Businesses | Citizens |
|---|---|---|
|
Employees in standard employment
|
Does not apply to businesses | Applies to all citizens |
| Actors | Funding |
|---|---|
|
Company / Companies
|
Employer
|
Social partners' role in designing the measure and form of involvement:
| Trade unions | Employers' organisations | |
|---|---|---|
| Role | No involvement | No involvement |
| Form | Not applicable | Not applicable |
Social partners' role in the implementation, monitoring and assessment phase:
Social partners were not involved.
No information available.
This case is sector-specific (only private sector)
| Economic area | Sector (NACE level 2) |
|---|---|
| C - Manufacturing | C20 Manufacture of chemicals and chemical products |
This case is not occupation-specific.
Citation
Eurofound (2020), Lesta starts production of disinfectant liquid, measure LT-2020-12/1389 (measures in Lithuania), EU PolicyWatch, Dublin, https://static.eurofound.europa.eu/covid19db/cases/LT-2020-12_1389.html
Share
All publications are available on the EU PolicyWatch landing page .
Disclaimer: This information has not been subject to the full Eurofound evaluation, editorial and publication process.